Cardio Diagnostics (CDIO) Competitors $0.38 -0.03 (-8.08%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$0.37 -0.01 (-2.05%) As of 03/28/2025 06:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CDIO vs. VIGL, ZURA, CLYM, IVVD, SLS, ACOG, RANI, CABA, VTGN, and HLVXShould you be buying Cardio Diagnostics stock or one of its competitors? The main competitors of Cardio Diagnostics include Vigil Neuroscience (VIGL), Zura Bio (ZURA), Climb Bio (CLYM), Invivyd (IVVD), SELLAS Life Sciences Group (SLS), Alpha Cognition (ACOG), Rani Therapeutics (RANI), Cabaletta Bio (CABA), Vistagen Therapeutics (VTGN), and HilleVax (HLVX). These companies are all part of the "pharmaceutical products" industry. Cardio Diagnostics vs. Vigil Neuroscience Zura Bio Climb Bio Invivyd SELLAS Life Sciences Group Alpha Cognition Rani Therapeutics Cabaletta Bio Vistagen Therapeutics HilleVax Vigil Neuroscience (NASDAQ:VIGL) and Cardio Diagnostics (NASDAQ:CDIO) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, institutional ownership, analyst recommendations, community ranking, profitability, risk and earnings. Do insiders and institutionals believe in VIGL or CDIO? 83.6% of Vigil Neuroscience shares are owned by institutional investors. Comparatively, 8.1% of Cardio Diagnostics shares are owned by institutional investors. 33.0% of Vigil Neuroscience shares are owned by insiders. Comparatively, 22.3% of Cardio Diagnostics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media refer more to VIGL or CDIO? In the previous week, Cardio Diagnostics had 1 more articles in the media than Vigil Neuroscience. MarketBeat recorded 3 mentions for Cardio Diagnostics and 2 mentions for Vigil Neuroscience. Vigil Neuroscience's average media sentiment score of 1.58 beat Cardio Diagnostics' score of 0.96 indicating that Vigil Neuroscience is being referred to more favorably in the media. Company Overall Sentiment Vigil Neuroscience Very Positive Cardio Diagnostics Positive Which has more volatility & risk, VIGL or CDIO? Vigil Neuroscience has a beta of 1.82, indicating that its stock price is 82% more volatile than the S&P 500. Comparatively, Cardio Diagnostics has a beta of 3.61, indicating that its stock price is 261% more volatile than the S&P 500. Do analysts rate VIGL or CDIO? Vigil Neuroscience presently has a consensus price target of $16.25, suggesting a potential upside of 750.79%. Cardio Diagnostics has a consensus price target of $2.00, suggesting a potential upside of 426.59%. Given Vigil Neuroscience's higher probable upside, research analysts clearly believe Vigil Neuroscience is more favorable than Cardio Diagnostics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vigil Neuroscience 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Cardio Diagnostics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is VIGL or CDIO more profitable? Vigil Neuroscience has a net margin of 0.00% compared to Cardio Diagnostics' net margin of -22,732.03%. Vigil Neuroscience's return on equity of -83.89% beat Cardio Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets Vigil NeuroscienceN/A -83.89% -65.34% Cardio Diagnostics -22,732.03%-258.85%-191.20% Which has better earnings and valuation, VIGL or CDIO? Cardio Diagnostics has higher revenue and earnings than Vigil Neuroscience. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVigil NeuroscienceN/AN/A-$82.64M-$2.06-0.93Cardio Diagnostics$34.89K567.63-$8.38MN/AN/A Does the MarketBeat Community believe in VIGL or CDIO? Vigil Neuroscience received 29 more outperform votes than Cardio Diagnostics when rated by MarketBeat users. Likewise, 84.62% of users gave Vigil Neuroscience an outperform vote while only 80.00% of users gave Cardio Diagnostics an outperform vote. CompanyUnderperformOutperformVigil NeuroscienceOutperform Votes3384.62% Underperform Votes615.38%Cardio DiagnosticsOutperform Votes480.00% Underperform Votes120.00% SummaryVigil Neuroscience beats Cardio Diagnostics on 10 of the 14 factors compared between the two stocks. Remove Ads Get Cardio Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for CDIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDIO vs. The Competition Export to ExcelMetricCardio DiagnosticsDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$19.81M$2.44B$5.63B$7.84BDividend YieldN/A0.72%5.33%4.01%P/E RatioN/A6.1123.6018.74Price / Sales567.6346.00388.2390.77Price / CashN/A15.7538.1734.64Price / Book2.712.986.894.23Net Income-$8.38M-$65.73M$3.20B$247.47M7 Day Performance-15.60%-4.54%-3.06%-2.29%1 Month Performance-15.47%-10.41%1.52%-5.81%1 Year Performance-73.25%-25.28%9.37%-0.96% Cardio Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDIOCardio Diagnostics2.8617 of 5 stars$0.38-8.1%$2.00+426.6%-73.3%$19.81M$34,890.000.001Short Interest ↓VIGLVigil Neuroscience3.9377 of 5 stars$1.90+0.5%$16.25+755.3%-44.0%$88.68MN/A-0.9240Short Interest ↓ZURAZura Bio2.1583 of 5 stars$1.35-2.9%$15.80+1,070.4%-50.8%$88.15MN/A0.003Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageCLYMClimb Bio3.0091 of 5 stars$1.32+1.5%$10.00+657.6%N/A$87.39MN/A-0.629Earnings ReportAnalyst RevisionNews CoverageGap DownIVVDInvivyd3.5379 of 5 stars$0.72-1.9%$7.89+989.4%-86.5%$86.60M$25.38M-0.37100Analyst ForecastShort Interest ↓News CoverageSLSSELLAS Life Sciences Group0.4708 of 5 stars$1.23+2.5%N/A+9.9%$86.57M$1M-1.7810News CoverageACOGAlpha Cognition2.0886 of 5 stars$5.33-0.7%$20.00+275.2%N/A$85.39MN/A-2.08N/AUpcoming EarningsAnalyst UpgradeNews CoverageGap UpRANIRani Therapeutics2.7699 of 5 stars$1.47-5.2%$12.33+739.0%-56.3%$84.22MN/A-1.39110News CoverageCABACabaletta Bio2.0149 of 5 stars$1.72-1.1%$22.71+1,220.6%-90.9%$84.07MN/A-0.8050VTGNVistagen Therapeutics2.0154 of 5 stars$2.91+4.3%N/A-50.9%$83.99M$698,000.00-1.9740Positive NewsHLVXHilleVax2.5046 of 5 stars$1.68flat$3.00+78.6%-90.4%$83.67MN/A-0.5420Earnings ReportNews Coverage Remove Ads Related Companies and Tools Related Companies VIGL Competitors ZURA Competitors CLYM Competitors IVVD Competitors SLS Competitors ACOG Competitors RANI Competitors CABA Competitors VTGN Competitors HLVX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CDIO) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardio Diagnostics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardio Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CDIO Stock Free CDIO Stock Alerts